Clariant’s Health Care business registered its maiden presence at the CPHI trade fair held at Noida from November 28-30, 2023. Some of the key products highlighted at CPhI are ‘Made in India’ at the Bonthapally site in Telangana:
- A) Vitipure Meglumine LEX – a low-endotoxin and microbial-load grade of meglumine. It is used as a counterion in contrast media sector, as a buffering agent/alkalizer and solubilizer for mild acidic APIs.
- B) VitiPure Superior – a high-purity brand that offers purified products via a patented process to minimise residual impurities in the product, which makes it colourless, odourless, with low microbial load and improves the stability of APIs.
Vaios Barlas, Global Head, Health Care, Clariant said, “For Clariant, India represents a dynamically growing market for functional excipients of high purity beyond just pharmacopeia compliance with an enormous potential into parenteral applications. Indian customers prefer excipient suppliers with stringent GMP track records and local manufacturing for shorter lead times. This was also evident from the very strong business connects we established at this event”.
Clariant Health Care is leveraging its expertise as a supplier to the pharmaceutical industry as a provider of:
- One-stop shop solution of excipients from standard to highly purified grades for unique application-specific formulation flexibility.
- Functional excipients to solve active pharmaceutical ingredient (API) delivery and bioavailability challenges
The press release stated that Clariant Health Care is a high-quality solution partner for the global pharmaceutical industry, with a strong portfolio of to performing excipients and active pharmaceutical ingredients (APIs), backed by operational excellence and years of experience in regulatory affairs.
